PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.74%
Some net income increase while MCHP is negative at -232.74%. John Neff would see a short-term edge over the struggling competitor.
4.29%
D&A growth well above MCHP's 1.39%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-5300.00%
Negative yoy deferred tax while MCHP stands at 556.86%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-37.84%
Negative yoy SBC while MCHP is 1.66%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
94.19%
Less working capital growth vs. MCHP's 1756.81%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
64.95%
AR growth well above MCHP's 53.11%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
55.17%
Inventory growth well above MCHP's 0.70%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
750.00%
AP growth well above MCHP's 251.79%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
1.97%
Lower 'other working capital' growth vs. MCHP's 693.74%. David Dodd would see fewer unexpected short-term demands on cash.
95.24%
Well above MCHP's 10.69%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
15.33%
Operating cash flow growth above 1.5x MCHP's 4.23%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-48.59%
Both yoy lines negative, with MCHP at -10.84%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
48.59%
Acquisition growth of 48.59% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-155.48%
Both yoy lines negative, with MCHP at -17.02%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
24.73%
We have some liquidation growth while MCHP is negative at -37.97%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-58.02%
Both yoy lines negative, with MCHP at -9.87%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-2082.72%
Both yoy lines negative, with MCHP at -84.15%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
We repay more while MCHP is negative at -279.22%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
-46.08%
Both yoy lines negative, with MCHP at -53.64%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-17.88%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.